A study of efficacy and safety of Transcatheter Arterial Embolization (TAE) with Embosphere for Polycystic liever disease.

A study of efficacy and safety of Transcatheter Arterial Embolization (TAE) with Embosphere for Polycystic liever disease. - Safety of Embosifere for polycystic liver disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010210

Enrollment

Registered

2013-03-11

Start date

2013-03-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic liver disease

Interventions

TAE with Embosphere

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) more than 20 years old 2) The patieng who are diacnosed by Computed Tomography, Magnetic resonance imaging or ultra sound and has a symptom such as abdominal distension, abdominal pain,behavioral disorder, respiration disorder, eating disorder,and back pain. 3) Child-Pugh score <6 4) A) Hemoglobin > 8 g/dL B) WBC >3000 /uL and <12000 /uL C) Platelet > 50000 /uL D) normal electocardiogram 5)Performance Status (ECOG)) is 0 to 2.

Exclusion criteria

Exclusion criteria: 1) CRP> 1.0mg/dL 2) Total Bilirubin > 3mg/dL 3) Obstruction of portal vein 4) cancer patient 5) iodine hypersensitivity 6) A patient with a lot of ascites 7) A patient with a lot ofpleural effusion 8) Pregnant women 9) Not eligible for this study based on the decision's of a physician

Design outcomes

Primary

Measure	Time frame
Safety(Liver disfunction,liver failure, biliary infection)	—

Secondary

Measure	Time frame
improvement of QOL, reduction of liver volume, change of liver function, change of the number of platelet, The rate of a technological success	—

Countries

Japan

Contacts

Public ContactTakashi Miyakoshi

Hokkaido University Hospotal Clinical Research and Medical Innovation Center Research and Development Division

mi_taka_1112@huhp.hokudai.ac.jp011-706-7923

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026